University of Gondar College of Medicine and Health Sciences, Gondar, Ethiopia.
Armeaur Hansen Research Institute, Addis Ababa, Ethiopia.
J Med Case Rep. 2024 Sep 8;18(1):415. doi: 10.1186/s13256-024-04724-8.
Familial adenomatous polyposis is characterized by the presence of multiple colorectal adenomatous polyps and caused by germline mutations in the tumor suppressor gene and adenomatous polyposis coli, located on chromosome 5q21-q22. Familial adenomatous polyposis occurs in approximately 1/10,000 to 1/30,000 live births, and accounts for less than 1% of all colorectal cancers in the USA. It affects both sexes equally and has a worldwide distribution. The incidence of colon cancer in low- and middle-income countries is rising. In addition to the increasing incidence, lack of early detection and impeded access to optimal multidisciplinary treatment may worsen survival outcomes. Developing quality diagnostic services in the proper health context is crucial for early diagnosis and successful therapy of patients with colorectal cancer, and applying a resource-sensitive approach to prioritize essential treatments on the basis of effectiveness and cost-effectiveness is key to overcoming barriers in low- and middle-income countries. We report a case of familial adenomatous polyposis presenting as adenocarcinoma with multiple colorectal adenomatous polyps. The diagnosis of familial adenomatous polyposis was made by the presence of numerous colorectal adenomatous polyps and family history of colonic adenocarcinoma. Due to its rarity, we decided to report it.
A 22-year-old Ethiopian female patient presented to Addis Ababa University College of Health science, Addis Ababa, Ethiopia with rectal bleeding. Abdominopelvic computed tomography scan was done and showed distal rectal asymmetric anterior wall thickening in keeping with rectal tumor. Colonoscopy was done and she was diagnosed to have familial adenomatous polyposis with severe dysplasia. In the meantime, colonoscopy guided biopsy was taken and the diagnosis of adenocarcinoma with familial adenomatous polyposis was rendered. For this, total proctocolectomy was carried out. On laparotomy there was also incidental finding of left ovarian deposition for which left salpingo-oophorectomy was done, and 4 weeks after surgical resection, the patient was started on oxaliplatin, leucovorin, fluorouracil chemotherapy regimen.
In the clinical evaluation of a patient with rectal bleeding, familial adenomatous polyposis must be considered as a differential diagnosis in subjects having family history of colonic adenocarcinoma for early diagnostic workup, management, family genetic counseling, and testing.
家族性腺瘤性息肉病的特征是存在多个结直肠腺瘤性息肉,由位于 5q21-q22 染色体上的肿瘤抑制基因和腺瘤性结肠息肉病的种系突变引起。家族性腺瘤性息肉病在活产儿中的发病率约为 1/10000 至 1/30000,在美国所有结直肠癌中所占比例不到 1%。它男女发病率相等,分布于世界各地。中低收入国家的结肠癌发病率正在上升。除了发病率的增加之外,缺乏早期发现和获得最佳多学科治疗的机会可能会使生存结果恶化。在适当的卫生环境中发展优质诊断服务对于结直肠癌患者的早期诊断和成功治疗至关重要,并且根据有效性和成本效益来应用资源敏感的方法对基本治疗进行优先级排序是克服中低收入国家障碍的关键。我们报告了一例家族性腺瘤性息肉病表现为结直肠癌伴多发性结直肠腺瘤性息肉的病例。家族性腺瘤性息肉病的诊断依据是存在大量结直肠腺瘤性息肉和家族性结肠腺癌病史。由于其罕见性,我们决定报告该病例。
一名 22 岁的埃塞俄比亚女性患者因直肠出血到埃塞俄比亚亚的斯亚贝巴大学健康科学学院就诊。进行了腹部骨盆计算机断层扫描,显示与直肠肿瘤一致的直肠远端不对称前壁增厚。进行了结肠镜检查,诊断为家族性腺瘤性息肉病伴重度异型增生。同时,进行了结肠镜引导下活检,诊断为腺癌伴家族性腺瘤性息肉病。为此,进行了全直肠结肠切除术。剖腹探查时还意外发现左侧卵巢沉积,因此进行了左侧输卵管卵巢切除术,手术后 4 周,开始给予奥沙利铂、亚叶酸钙、氟尿嘧啶化疗方案。
在对直肠出血患者进行临床评估时,对于有家族性结肠腺癌病史的患者,必须将家族性腺瘤性息肉病作为鉴别诊断,以便进行早期诊断、治疗、家族遗传咨询和检测。